Status:
ACTIVE_NOT_RECRUITING
Visual Field Analysis With Artificial Intelligence
Lead Sponsor:
Sight Intelligence Engineering Corporation
Conditions:
Glaucoma
Visual Field Defect
Eligibility:
All Genders
18-100 years
Brief Summary
The purpose of this study is to analyze visual field data from healthy participants. This data will be used to develop and optimize a new visual field perimeter test. The test will incorporate an adva...
Detailed Description
RESEARCH PROTOCOL Study Title: Optimizing Visual Field Analysis using Artificial Intelligence: Establishing Normal Threshold Values for Healthy Participants Using a Visual Field Perimeter Principal...
Eligibility Criteria
Inclusion
- Healthy adults aged 18 years or older.
- Best corrected visual acuity of 20/40 or better in each eye.
- Normal optic nerve appearance upon clinical examination.
Exclusion
- Best corrected visual acuity worse than 20/40.
- Cup-to-disc ratio greater than 0.5.
- Previously documented glaucoma or optic neuropathy.
- Any significant ocular or neurological condition that may impact visual field.
- Inability to comply with study procedures.
Key Trial Info
Start Date :
July 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 31 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06920290
Start Date
July 1 2025
End Date
August 31 2026
Last Update
November 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sight Intelligence Engineering
Alexandria, Virginia, United States, 22306